Who has invested in Aravax?

Brandon Capital are named among the investors backing Aravax.

Aravax Funding: $42M Raised, Series B (2023)

Aravax funding overview

Aravax is based in Melbourne, Australia. Aravax has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for Aravax runs through 2023; nothing later has been disclosed. Investors on record include Brandon Capital.

Aravax at a glance

Total raised: $42M
Latest round: Series B
Latest round date: January 2023
Headquarters: Melbourne, Australia
Notable investors: Brandon Capital

Frequently asked about Aravax funding

How much has Aravax raised?: Aravax has raised $42M in total disclosed funding across the rounds on record.
Who has invested in Aravax?: Brandon Capital are named among the investors backing Aravax.
What was the latest Aravax funding round?: The most recent disclosed round is a Series B, announced in January 2023.
Where is Aravax based?: Aravax is based in Melbourne, Australia.
When did Aravax last raise?: The last disclosed Aravax round closed in January 2023 at Series B.

Every Aravax figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Melbourne at a similar stage.

Aravax Funding: $42M Raised, Series B (2023)

Aravax funding overview

Aravax at a glance

Frequently asked about Aravax funding

Companies related to Aravax (26)

Browse related funding lists (4)